Virology
TWiV 946: Poo vs flu
By Vincent Racaniello | | This Week in Virology
Angela Mingarelli joins TWiV to discuss whether the gut microbiota of bats confers tolerance to influenza virus infection in mice, and primate hemorrhagic fever-causing arteriviruses that can reproduce in human cells and might be capable of infecting humans.
TWiV 945: Clinical update with Dr. Daniel Griffin
By Vincent Racaniello | | This Week in Virology
In his weekly clinical update Dr. Griffin discusses a healthcare-associated infection with Monkeypox virus, air and surface sampling for monkeypox virus in a UK hospital, misrepresentation and nonadherence regarding COVID19 public health measures, tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine, clinical, virologic, and immunologic evaluation of symptomatic rebound following Nirmatrelvir/Ritonavir treatment, early outpatient treatment with Eemdesivir in patients at high risk for severe COVID-19, Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes, and outcomes among confirmed cases and a matched comparison group in the long-COVID in Scotland.
TWiV 944: Hacking through Borneo with Kathryn Hanley
By Vincent Racaniello | | This Week in Virology
Kathryn Hanley joins TWiV to discuss her career and the research in her laboratory on the molecular biology, evolution and ecology of emerging RNA viruses and their insect vectors.
TWiV 943: Clinical update with Dr. Daniel Griffin
By Vincent Racaniello | | This Week in Virology
In his weekly clinical update Dr. Griffin discusses high points of the multi-national monkeypox outbreaks, monkeypox virus genome mutations, possible occupational infection of healthcare workers with monkeypox virus, rates of monkeypox cases by vaccination status, protection of SARS-CoV-2 infection against reinfection, Paxlovid significantly reduces COVID-19 hospitalizations and deaths, and rebound in COVID19 with and without Paxlovid treatment.
Why do Some People Develop Long COVID?
By Gertrud U. Rey | | Basic virology, Gertrud Rey
by Gertrud U. Rey Long COVID is a chronic manifestation of SARS-CoV-2 infection, and it is most commonly characterized by lingering fatigue, brain fog, memory impairment, and confusion. Although it is unclear how the viral infection leads to long COVID, experts speculate that one or more of the following factors may contribute: an inability to …
TWiV 932: Omicron boosters with Paul Offit
By Vincent Racaniello | | This Week in Virology
Paul Offit returns to TWiV for a discussion of SARS-CoV-2 bivalent boosters containing ancestral and Omicron spike mRNAs, including their composition, why they are being recommended by CDC, and who would benefit the most from them.
David Tuller
Trial By Error: Anil van der Zee’s New Video on Living with Severe ME
By David Tuller, DrPH *This is a crowdfunding month for Trial By Error. Donations (tax-deductible to US tax-payers) go to the University of Calinfornia, Berkeley, to support the project. The link to the crowdfunding campaign is here: https://crowdfund.berkeley.edu/project/42302 ********** Anil van der Zee and I first connected in 2016, when he invited me to Amsterdam to …
Trial By Error: Anil van der Zee’s New Video on Living with Severe ME Read More »
Trial By Error: Time’s Health100 List Includes Leaders in Long Covid and ME/CFS
By David Tuller, DrPH *This is a crowdfunding month for Trial By Error. Donations (tax-deductible to US tax-payers) go to the University of Calinfornia, Berkeley, to support the project. The link to the crowdfunding campaign is here: https://crowdfund.berkeley.edu/project/42302 Last week, Time magazine unveiled a list called the TIME100 Health—a selection of “leaders from across industries—scientists, doctors, …
Trial By Error: Time’s Health100 List Includes Leaders in Long Covid and ME/CFS Read More »
Trial By Error: A Conversation with the Co-Founders of The Sick Times
By David Tuller, DrPH *This is a crowdfunding month for Trial By Error. Donations (tax-deductible to US tax-payers) go to the University of Calinfornia, Berkeley, to support the project. The link to the crowdfunding campaign is here: https://crowdfund.berkeley.edu/project/42302 Journalists Betsy Ladyzhets and Miles Griffis are the co-founders of The Sick Times, a non-profit that covers …
Trial By Error: A Conversation with the Co-Founders of The Sick Times Read More »
Trial By Error: Interview with Co-Organizator of Next Week’s Unite To Fight Long Covid and ME/CFS Conference
By David Tuller, DrPH *This is a crowdfunding month at Berkeley for Trial By Error. If you appreciate my work, here’s a link to donate (tax-deductible to US taxpayers) directly to the university: https://crowdfund.berkeley.edu/project/42302 ********** Marco Wetzel, a digital sales expert, is one of five German Long Covid patients who banded together earlier this year …
Trial By Error: Berkeley’s May Crowdfunding Campaign Begins…
By David Tuller, DrPH Berkeley’s latest crowdfunding campaign for Trial By Error begins today. It is hard for me to believe that I have been working on this project—debunking awful research into what was then called “chronic fatigue syndrome,” and related issues–for ten years. My efforts began in the summer of 2014, when I traveled …
Trial By Error: Berkeley’s May Crowdfunding Campaign Begins… Read More »
Trial By Error: Australian GP Group Recommends “Incremental Physical Activity” for “CFS/ME” Patients
By David Tuller, DrPH What’s going on with Aussie members of the graded exercise therapy cult? (Oops!—I meant the Royal Australian College of General Practitioners, a trade and professional organization. Sorry!) In 2019, I wrote about the organization’s guidance for “CFS/ME.” This guidance, published in 2015, was part of the group’s Handbook of Non-Drug Interventions …